vision biosystems

Vision BioSystems manufactures sophisticated instrument platforms for the clinical diagnostic market. The Newcastle (UK) based reagent development and manufacturing operation ensures that the instrument platforms are accompanied by high quality, tailored Novocastra-branded reagents to provide the market with totally automated laboratory solutions and to generate a high value, recurring revenue stream for Vision BioSystems.

instrument systems

The company invests heavily in product development and maintains an in-depth product development group with a wealth of knowledge and experience in the automation of clinical diagnostic products. Vision BioSystems also has the advantage of being able to call upon Invetech's product development skills.

Vision BioSystems' customer-focused approach to product development ensures the end product fits the needs of the clinical laboratory.

monoclonal antibodies and ancillary reagents

The company researches, develops and manufactures high quality primary antibodies, probes and reagents for clinical pathology and life sciences research.

With the Novocastra brand recognised as one of the world's top three, the company is highly regarded in the cancer detection market. It is seen as being technically superior and as a provider of a range of unique primary antibodies, many of which are utilised in diagnostic tests marketed by other companies.

  Vision BioSystems

© Copyright Vision Systems Pty Ltd. 2007. Vision Systems Pty Ltd. and logo design are trademarks of Vision Systems Pty Ltd.